Liquid Chromatography Mass Spectrometry (LCMS) Market Gas Gained Tremendous Demand In The Recent Years On The Account Of Expanding Healthcare Industry

 

Liquid Chromatography Mass Spectrometry (LCMS) Market

Liquid chromatography mass spectrometry (LCMS) market has become a common method with the evolution of Electrospray Ionization (ESI) giving a robust and simple interface to perform analysis of proteins, DNA/RNA, and other substances. It can also be employed to identify analytes in the solid phase without the need for additional digestion. The use of tandem mass spectrometry and equilibrium independent chromatography methods allows for accurate measurements of amounts and concentrations of hundreds of thousands of single particles and thousands of molecular clusters. It has enabled the detection of novel drugs, regulated substances, quality indicators in food and chemical databases, and produced a reliable quantitative analysis of water and human tissue samples.

The use of liquid chromatography mass spectrometry (LCMS) market is not limited to the pharmaceutical or industrial environment, as it is also widely used in the medical field for the diagnosis and treatment of disease and medical conditions including diabetes, inflammatory bowel diseases, Parkinson's disease, eye disorders, sinusitis, throat problems, cancer, and acne.

Growing investment in the research and development activities across medical industry is primarily fueling the growth of the liquid chromatography mass spectrometry (LCMS) market. The increasing focus of key manufacturers on introducing an innovative product in order to cater to rising demand is again projected to foster the growth of the market. For instance, in January 2019, Waters introduced the BioAccord System, a new, purposefully designed liquid chromatography mass spectrometry (LCMS) system that is expected to expand access to high-resolution time-of-flight mass spectrometry capabilities to more scientists. The new system provides the advantage of moving routine monitoring out of centralized MS labs, allowing more scientists to use it.

On the other hand, the high cost associated with the liquid chromatography-mass spectrometry systems is projected to hinder the growth of the market. Thermo Fisher Partners with Newomics, Evosep, Biognosys for liquid chromatography mass spectrometry (LCMS) applications, to develop and optimize new microflow LCMS workflows for the validation of disease biomarkers.

Key Developments:

1.      In January 2021, Protein Metrics and MOBILion Systems announce their strategic partnership to provide data analysis modules for Protein Metrics’ Byos software suite that works exclusively with MOBILion’s High-Resolution Ion Mobility (HRIM) Mass Spectrometry (MS) System

2.      In January 2021, SCIEX has acquired Intabio, a privately held company and the developer of the Blaze™ System for biotherapeutic analysis and quality assessment. Blaze enables the direct coupling of imaged cIEF charge variant analysis with high-resolution mass spectrometry to detect intact proteins.


Comments

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

The market for ureteral stents would benefit from the rising prevalence of urological diseases

The North America Vision Care Market Is Driven by the Increasing Prevalence of Eye Diseases in this Region